I agree with you about the science and FDA...particularly the FDA. It is the bottleneck once approved that I have problems with. Vivagel has been approved in Australia for over a year and in Europe for years. Why is it not on the shelves? Why is it not listed in Australian Medication References that are updated at least monthly. No advertising in Pharmacy journals. What is Aspen doing? We were told two AGMs ago that it would be on the shelves by now. By the end of this half year is the latest estimate....I don't believe them. I have lost faith in their ability to market a product (or choose a company that can market a product). I believe in the science, but there is a bottle neck when trying to get to market. Will the same thing happen when the DEP program is ready to market?? Will it still be relevant when it finally gets to market?
I agree with you about the science and FDA...particularly the...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.82M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
